Filtering High-throughput Protein-protein Interaction Data Using a Combination of Genomic Features
Overview
Authors
Affiliations
Background: Protein-protein interaction data used in the creation or prediction of molecular networks is usually obtained from large scale or high-throughput experiments. This experimental data is liable to contain a large number of spurious interactions. Hence, there is a need to validate the interactions and filter out the incorrect data before using them in prediction studies.
Results: In this study, we use a combination of 3 genomic features -- structurally known interacting Pfam domains, Gene Ontology annotations and sequence homology -- as a means to assign reliability to the protein-protein interactions in Saccharomyces cerevisiae determined by high-throughput experiments. Using Bayesian network approaches, we show that protein-protein interactions from high-throughput data supported by one or more genomic features have a higher likelihood ratio and hence are more likely to be real interactions. Our method has a high sensitivity (90%) and good specificity (63%). We show that 56% of the interactions from high-throughput experiments in Saccharomyces cerevisiae have high reliability. We use the method to estimate the number of true interactions in the high-throughput protein-protein interaction data sets in Caenorhabditis elegans, Drosophila melanogaster and Homo sapiens to be 27%, 18% and 68% respectively. Our results are available for searching and downloading at http://helix.protein.osaka-u.ac.jp/htp/.
Conclusion: A combination of genomic features that include sequence, structure and annotation information is a good predictor of true interactions in large and noisy high-throughput data sets. The method has a very high sensitivity and good specificity and can be used to assign a likelihood ratio, corresponding to the reliability, to each interaction.
Heterogeneous network approaches to protein pathway prediction.
Nayar G, Altman R Comput Struct Biotechnol J. 2024; 23:2727-2739.
PMID: 39035835 PMC: 11260399. DOI: 10.1016/j.csbj.2024.06.022.
AURKA inhibition induces Ewing's sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis.
Chen H, Hu J, Xiong X, Chen H, Lin B, Chen Y Cell Death Dis. 2024; 15(1):99.
PMID: 38287009 PMC: 10825207. DOI: 10.1038/s41419-024-06485-0.
Fu Y, Jia Q, Ren M, Bie H, Zhang X, Zhang Q Immun Ageing. 2023; 20(1):66.
PMID: 37990246 PMC: 10662463. DOI: 10.1186/s12979-023-00386-0.
Computational approaches for the design of modulators targeting protein-protein interactions.
Rehman A, Khurshid B, Ali Y, Rasheed S, Wadood A, Ng H Expert Opin Drug Discov. 2023; 18(3):315-333.
PMID: 36715303 PMC: 10149343. DOI: 10.1080/17460441.2023.2171396.
BTC as a Novel Biomarker Contributing to EMT the PI3K-AKT Pathway in OSCC.
Shen T, Yang T, Yao M, Zheng Z, He M, Shao M Front Genet. 2022; 13:875617.
PMID: 35846125 PMC: 9283838. DOI: 10.3389/fgene.2022.875617.